EichorEICHOR
Location: Charlottesville Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Charlottesville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · University of Virginia Cancer Center ( Site 0040) · Merck Sharp & Dohme LLC · NCT06136559Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Scho
NA · University of Virginia · University of Virginia · NCT06047041Incremental Hemodialysis: The TwoPlus Trial
NA · University of Virginia (UVA) · Wake Forest University Health Sciences · NCT05828823Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · University of Virginia Health System · Bristol-Myers Squibb · NCT07106762MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · University of Virginia Cancer Center · National Cancer Institute (NCI) · NCT05564390A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · University of Virginia Cancer Center · National Cancer Institute (NCI) · NCT05099003A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Phase 1/Phase 2 · University of Virginia · Chordia Therapeutics, Inc. · NCT05732103Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
NA · UVA Health · Washington University School of Medicine · NCT05991453Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · University of Virginia Cancer Center · National Cancer Institute (NCI) · NCT06172296Spinal Cord Injury Registry - North American Clinical Trials Network
Phase N/A · University of Virginia Health System · Robert G. Grossman, MD · NCT00178724Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
NA · University of Virginia Health System · University of Virginia · NCT05653518Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NA · University of Virginia · Perspectum · NCT04054310Colchicine in Acutely Decompensated HFREF
Phase 4 · UVA Health · University of Virginia · NCT06286423PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Phase 3 · University of Virginia (UVA) · Duke University · NCT07232069A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Phase 2 · UVA Health · Verastem, Inc. · NCT07644559A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · University of Virginia Cancer Center · Children's Oncology Group · NCT06368817The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · University of Virginia · University of Oxford · NCT05169333A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · University of Virginia Cancer Center · National Cancer Institute (NCI) · NCT05691478Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
Phase 1 · UVA Health · University of Virginia · NCT06600178Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With P
Phase 2 · University of Virginia Health System · Greg Durm, MD · NCT04317534A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · University of Virginia Cancer Center ( Site 5044) · Merck Sharp & Dohme LLC · NCT07216703StrokeNet Thrombectomy Endovascular Platform
NA · UVA Medical Center · Medical University of South Carolina · NCT06289985Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · University of Virginia Health System · Eli Lilly and Company · NCT06890598STIMIT Activator 1 IDE Study
NA · University of Virginia Medical Center · Stimit AG · NCT05883163A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · University of Virginia · Eli Lilly and Company · NCT07222332FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · University of Virginia · Parabilis Medicines, Inc. · NCT05919264The Influence of Prescribed Exercise on Pain Related Fear Following Concussion in Collegiate Athletes
NA · University of Virginia Department of Kinesiology · University of Virginia · NCT06246669A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · University of Virginia Cancer Center · Children's Oncology Group · NCT04322318A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · University of Virginia Comprehensive Cancer Center · UroGen Pharma Ltd. · NCT06774131
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.